Compare NeueHealth (NEUE) with the competition

NeueHealth ( NYSE:NEUE – Get Free Report ) is one of 14 publicly traded companies in the “hospital and medical service plans” industry, but how does it compare to its competitors? We will compare NeueHealth to peer companies based on dividend strength, valuation, earnings, risk, analyst recommendations, institutional ownership, and profitability.

Analyst Ratings

This is an overview of the current recommendations for NeueHealth and its competitors, as provided by

Sales reviews Hold reviews Buy reviews Strong Buy Ratings Review score
NeueHealth 0 1 0 0 2.00
NeueHealth Competitors 94 1117 2563 98 2.69

NeueHealth currently has a consensus price target of $8.00, which suggests a potential upside of 37.46%. As a group, companies with “hospital and medical service plans” have a potential upside rate of 14.74%. Given NeueHealth’s more likely advantage, research analysts clearly believe NeueHealth is more favorable than its competitors.

Earnings and Valuation

This table compares the revenue, earnings per share and valuation of NeueHealth and those of its competitors.

Gross income Net income Price/earnings ratio
NeueHealth $1.16 billion -$1.15 billion -0.04
NeueHealth Competitors $80.60 billion $2.78 billion 9.54

NeueHealth’s competitors have higher sales and profits than NeueHealth. NeueHealth trades at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its sector.


This table compares NeueHealth’s net margins, return on equity, and return on assets with those of its competitors.

Net margins Return on equity Return on assets
NeueHealth -71.23% N/A -1.21%
NeueHealth Competitors -0.11% -1.57% -0.01%

Insider and institutional ownership

63.9% of NeueHealth shares are owned by institutional investors. By comparison, 80.4% of the shares of all companies with ‘hospital and medical service plans’ are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. In comparison, 10.2% of the shares of all companies with ‘hospital and medical service plans’ are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility and risk

NeueHealth has a beta of 0.84, which indicates that its stock price is 16% less volatile than the S&P 500. In comparison, NeueHealth’s peers have a beta of 0.95, which indicates that their average stock price is 5% less more volatile than the S&P 500.


NeueHealth’s competitors beat NeueHealth on 10 of the 13 factors compared.

NeueHealth Company Profile

(Get a free report)

NeueHealth, Inc., a healthcare company, provides a variety of healthcare services to healthcare consumers, healthcare providers and payers in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment provides healthcare services to the ACA marketplace, Medicare and Medicaid through owned and affiliated clinics. It operates high-risk clinics under the brand names Centrum Health, AssociatesMD and Premier Medical Associates. The company also provides integrated system healthcare solutions, such as integrated pharmacy, laboratory, radiology and public health-oriented specialty services; and chronic care management, care transitions, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the Centers for Healthcare Access for Medicare Beneficiaries. The company was previously called Bright Health Group, Inc. and changed the name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was founded in 2015 and is headquartered in Doral, Florida.

Receive daily news and reviews for NeueHealth – Enter your email address below to receive a daily digest of the latest news and analyst ratings for NeueHealth and related companies with’s FREE daily email newsletter.